ENZYMINHIBITOREN
Patent europeic · EP1963315 · En vigur
Inscripziun en il register
- Numer da publicaziun
- EP1963315
- Numer da la dumonda
- EP06820620
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- En vigur
- Scrittira da patent
- Concedì
- Annunzià
- 21-12-2006
- Publitgà
- 03-09-2008
- Concedì
- 08-10-2014
- La protecziun finescha il pli tard
- 20-12-2026
- Proxima taxa annuala scadenta
- 31-12-2026
- Classas IPC
- C07D 471/04 (2006.01)A61K 31/437 (2006.01)A61P 37/08 (2006.01)
- Prioritad
- GB 0526169 22.12.2005GB 0620884 20.10.2006
- Dumonda PCT
- PCT/GB2006/004854 21.12.2006
- Publicaziun PCT
- WO2007/072017 28.06.2007
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 01-01-2026
Midada
Published in Swissreg on 01.01.2026
- 01-01-2025
Midada
Published in Swissreg on 01.01.2025
- 01-01-2024
Midada
Published in Swissreg on 01.01.2024
- 01-01-2023
Midada
Published in Swissreg on 01.01.2023
- 04-04-2020
Transferì
- Owner
- Cancer Research Technology Limited, Angel Building, 407 St John Street, London, EC1V 4AD, United Kingdom → The Institute of Cancer Research: Royal Cancer, Hospital, 123 Old Brompton Road, London SW7 3RP, United Kingdom
Published in Swissreg on 04.04.2020
- 07-02-2015
Represchentant inscrit
- Representative
- MICHELI & CIE SA, 122, Rue de Genève, Case postale 61, 1226 Thônex
Published in Swissreg on 07.02.2015
- 08-10-2014
Concedì
Published in Swissreg on 08.10.2014
Partidas
Possessur
Inventur
Sutton, Surrey SM2 5NG, GB
Sutton, Surrey SM2 5NG, GB
Sutton, Surrey SM2 5NG, GB
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.